Grifols, S.A. (GIKLY) — Business segments and KPIs
Revenue by business segment and geography for Grifols, S.A., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Haemoderivatives | 6.49B | 86.2% |
| Transfusional medicine | 623M | 8.3% |
| Other Product | 243M | 3.2% |
| Bio supplies | 154M | 2.0% |
| Other diagnostic | 17.00M | 0.2% |
| Revenue by region | ||
| USA and Canada. | 4.25B | 59.9% |
| Rest of the world | 1.66B | 23.3% |
| Rest of European Union | 1.20B | 16.8% |